Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_assertion type Assertion NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_head.
- NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_assertion description "[The aim of this study was to investigate how ATF6 and PERK signaling affected misfolded rhodopsin in cells, which could identify new molecular therapies to treat retinal diseases associated with ER protein misfolding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_provenance.
- NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_assertion evidence source_evidence_literature NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_provenance.
- NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_assertion SIO_000772 22956602 NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_provenance.
- NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_assertion wasDerivedFrom befree-2016 NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_provenance.
- NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_assertion wasGeneratedBy ECO_0000203 NP1011005.RAJNcJmjDdkUhwhVvf6QNZ4HEE662YLb6B0fu8iu83Eks130_provenance.